Cloned (Comment) | Organism |
---|---|
expression in Escherichia coli | Mus musculus |
expression in Escherichia coli | Drosophila melanogaster |
Crystallization (Comment) | Organism |
---|---|
structure of isoform NMNAT3 to 2 A resolution | Mus musculus |
Protein Variants | Comment | Organism |
---|---|---|
E198P/L217R | mutation disrupts the dimer interface, leading to a mixture of dimer and monomer in solution | Mus musculus |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
64000 | - |
gel filtration | Mus musculus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Drosophila melanogaster | Q9VC03 | cf. EC 2.7.7.1 | - |
Mus musculus | Q99JR6 | isoform NMNAT3, cf. EC 2.7.7.1 | - |
Subunits | Comment | Organism |
---|---|---|
dimer | 2 * 27700, calculated from sequence, and crystallization data | Mus musculus |
Synonyms | Comment | Organism |
---|---|---|
NMNAT3 | cf. EC 2.7.7.1 | Mus musculus |
General Information | Comment | Organism |
---|---|---|
physiological function | NMNAT serves as a chaperone of phosphorylated Tau to prevent its amyloid aggregation in vitro as well as mitigate its pathology in Drosophila tauopathy models overexpressing human Tau. NMNAT adopts its enzymatic pocket to specifically bind the phosphorylated sites of Tau, which can be competitively disrupted by the enzymatic substrates of NMNAT. NMNAT serves as a cochaperone of Hsp90 for the specific recognition of phosphorylated Tau over Tau | Drosophila melanogaster |
physiological function | NMNAT shows strong interaction with phosphorylated truncated Tau protein. The binding affinity of NMNAT3 to phosphorylated Tau is about one order of magnitude higher than that to Tau.The phosphorylated Ser residues of Tau are the primary binding sites. Substrates (i.e. NMN and ATP) and the chaperone client phosphorylated Tau share the same binding pocket with a partial overlap at the phosphate-binding site | Mus musculus |